Approval · Notice of Compliance 15049 · 2013
PROMETRIUM: Notice of Compliance 15049
Issued December 20, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15049
- Date
- December 20, 2013
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- A new manufacturing site
- Therapeutic class
- Progestin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROMETRIUM | Not yet assigned | — |
Medicinal ingredients
- PROGESTERONE 100 MG per CAP